AIBullishFortune Crypto · 3h ago7/10
🧠
The CEO who loves AI autodidacts — and desperately needs his experts
Amgen CEO Bob Bradway made early bets on AI in biotech, positioning the company to leverage artificial intelligence for drug discovery and development. The strategy is now generating measurable returns while forcing the organization to navigate tensions between AI-driven automation and the need for specialized scientific expertise.
